Company / Capital Expenditures
Imunon, Inc. Capital Expenditures History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$267.8K
FY2023
5-year range
$19.1K / $349.2K
FY2019-FY2023
Trend
-14.1%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 7 years, ranging from $19,092 in FY2021 to $349,158 in FY2020.
Based on SEC 10-K filings.
$267,800 in FY2023 with a 5-year CAGR of +47.3%.
Improved from $19,092 to $267,800 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -8.5%
- 5-Year CAGR
- +47.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +47.3%, indicating consistent growth.
- In FY2023, capital expenditures decreased 14.1% year-over-year.
- Peak capital expenditures was recorded in FY2020.
- Lowest capital expenditures in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $267.8K | -14.1% |
| FY2022 | $311.6K | +1532.2% |
| FY2021 | $19.1K | -94.5% |
| FY2020 | $349.2K | +152.3% |
| FY2019 | $138.4K | +258.3% |
| FY2018 | $38.6K | -32.8% |
| FY2015 | $57.5K | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026